Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | NPEPPS | P55786 | 2/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | IAPP | P10997 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6232528 | 0.87 | GABRA1 (0.48) | GABRA1GABRB2NPEPPSELANEALDH1A1 | |
| SCHEMBL14462113 | 0.78 | ELANE (0.37) | GABRA1GABRB2ELANEKDM4EALDH1A1 | |
| SCHEMBL170762 | 0.78 | LIPG (0.52) | — | |
| SCHEMBL31613870 | 0.77 | GABRA1 (0.46) | GABRA1GABRB2ATMDAO | |
| SCHEMBL327380 | 0.77 | GABRA1 (0.46) | GABRA1GABRB2ATMDAO | |
| SCHEMBL28434207 | 0.76 | LIPG (0.55) | — | |
| SCHEMBL11050977 | 0.76 | CNR2 (0.45) | ATMELANEKDM4EALDH1A1GAA | |
| SCHEMBL8521819 | 0.75 | MAOA (0.41) | ELANEKDM4EALDH1A1HPGD | |
| SCHEMBL66918 | 0.74 | CYP1A2 (0.55) | ATM | |
| SCHEMBL142479 | 0.74 | ADRA2B (0.44) | GABRA1GABRB2KDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11765968-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11765968-B2 | Organic electroluminescent materials and devices | TPR, TPO, DDT | GABRA1 3784/4885GABRB2 3147/4885ATM 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.